Literature DB >> 17024108

High-performance liquid chromatography method for rapid assessment of viral particle number in crude adenoviral lysates of mixed serotype.

I Kuhn1, B Larsen, C Gross, T Hermiston.   

Abstract

Accurate adenovirus (Ad) quantification requires labor- and time-intensive viral stock purification. While crude viral lysates can be titered by plaque assay, this cell-based assay is neither rapid nor accurate. Consequently, a method for quantification of crude, unpurified viral culture lysates is needed. Given growing interest in alternative Ad serotypes (different from well-studied and characterized serotype Ad5) for basic research and for therapeutic applications, such a method should also apply to alternative serotypes. Using a Q Sepharose XL (QSXL) column-based method, we describe a robust quantification method resulting in efficient retention of viral particles of all serotypes, while non-viral components of crude infected cultures remain largely in the flow-through. The high-performance liquid chromatography-QSXL method allows rapid, accurate adenoviral quantification in crude lysates as well as identification of the various serotypes present in mixed-serotype crude lysates. We also report on conditions that efficiently strip and regenerate the column, extending its functional life.

Entities:  

Mesh:

Year:  2006        PMID: 17024108     DOI: 10.1038/sj.gt.3302851

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  7 in total

1.  Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement.

Authors:  Zhili Xu; Jie Tian; Jeffrey S Smith; Andrew P Byrnes
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

2.  Oncolytic viruses: the power of directed evolution.

Authors:  Maxine Bauzon; Terry W Hermiston
Journal:  Adv Virol       Date:  2011-07-24

3.  OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution.

Authors:  Irene Kuhn; Maxine Bauzon; Nicola Green; Len Seymour; Kerry Fisher; Terry Hermiston
Journal:  Mol Ther Oncolytics       Date:  2016-12-14       Impact factor: 7.200

Review 4.  Considerations for bioanalytical characterization and batch release of COVID-19 vaccines.

Authors:  Gautam Sanyal; Anna Särnefält; Arun Kumar
Journal:  NPJ Vaccines       Date:  2021-04-13       Impact factor: 7.344

5.  Identification of Recombinant Chimpanzee Adenovirus C68 Degradation Products Detected by AEX-HPLC.

Authors:  Thomas W Powers; Elise K Mullins; Kun Zhang; Joseph J Binder; Olga Friese; Herbert A Runnels; Lawrence C Thompson
Journal:  Front Bioeng Biotechnol       Date:  2022-04-05

6.  Experimental Evaluation of an Interferometric Light Microscopy Particle Counter for Titering and Characterization of Virus Preparations.

Authors:  Vesa Turkki; Elisa Alppila; Seppo Ylä-Herttuala; Hanna P Lesch
Journal:  Viruses       Date:  2021-05-19       Impact factor: 5.048

7.  Directed evolution generates a novel oncolytic virus for the treatment of colon cancer.

Authors:  Irene Kuhn; Paul Harden; Maxine Bauzon; Cecile Chartier; Julie Nye; Steve Thorne; Tony Reid; Shaoheng Ni; Andre Lieber; Kerry Fisher; Len Seymour; Gabor M Rubanyi; Richard N Harkins; Terry W Hermiston
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.